Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade and Irinotecan in Advanced Gynecologic Cancers
NCT00106262Phase 2Terminated
- Sponsor
- Women & Infants Hospital
- Start
- Mar 2005
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in Cervical Cancer (CC), vaginal cancer, vulvar cancer, sponsored by Women & Infants Hospital. Started Mar 2005; status: terminated.
02
Drugs
bortezomib
03
Conditions
Cervical Cancer (CC)vaginal cancervulvar cancer
Beyond the preview
Go deeper on NCT00106262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106262.